Kettering General Hospital is an NHS hospital in Kettering, Northamptonshire, England. It is managed by the Kettering General Hospital NHS Foundation Trust.

There are 600 beds in Kettering General Hospital.

During the past decade, Kettering General Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kettering General Hospital" #1 sponsor was "Coloplast A/S" with 3 trials, followed by "South Tyneside and Sunderland NHS Foundation Trust" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Lymphoma Trials Office" with 2 trials sponsored and "Terumo Europe N.V." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kettering General Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "Lymphoma Trials Office" with 3 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 2 trials as a collaborator and "Kettering General Hospital NHS Foundation Trust" with 2 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "Kettering General Hospital" are "Lymphoma" (5 trials), "Colorectal Adenoma" (3 trials), "Coronary Artery Disease" (3 trials), "Acute Coronary Syndrome" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Kettering General Hospital" in a lesser frequency.

Most popular intervention types in "Kettering General Hospital" are "Drug" (13 trials), "Device" (9 trials), "Biological" (6 trials), "Procedure" (5 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "etoposide" (3 trials), "Colonoscopy" (2 trials), "Cyclophosphamide" (2 trials) and "Prednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kettering General Hospital" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Kettering General Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Kettering General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kettering General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".